宋雪皎，女，博士，四川大學華西公共衛生學院實驗師。
基本介紹
- 中文名：宋雪皎
- 國籍：中國
- 畢業院校：四川大學
- 學位/學歷：博士
- 性別：女
- 職稱：實驗師
基本情況,人物經歷,承擔課程,主持項目,代表性論著,
基本情況
宋雪皎，女，1989.08。四川大學華西公共衛生學院 實驗師
人物經歷
2007年09月-2011年06月，四川大學，藥學院藥物化學，學士
2011年09月-2016年06月，四川大學，生物治療國家重點實驗室，碩博連讀，博士
2016年 10 月 – 至今，四川大學華西公共衛生學院實驗師
承擔課程
《分析化學實驗》《衛生化學實驗》《空氣水質理化檢驗實驗》
主持項目
國家自然科學基金青年項目，81702946，EZH2在直腸癌幹細胞中的作用機制及小分子靶向治療的研究，2018/01-2020/12，20萬元，在研，主持
代表性論著
(1)AipingFang, Shijie Zhou,XiaolanSu,Liu Chuang, Ciaoxin Chen, YangWan, Xiaohong Lei,LinshenXie, Yiping Jia, Wenzhi Wang,Luo Yang*,XuejiaoSong*, YuqinYao. RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival,Future Oncol.2018 Jun 8.
(2) Xuejiao Song, Tiantao Gao, Qian Lei, Lidan Zhang, Yuqin Yao, Jingyuan Xiong* ,Piperlongumine induces apoptosis in human melanoma cells via mitochondria related intrinsic apoptotic pathway,Nutr Cancer.2018 Apr;70(3):502-511.
(3)Xuejiao Song, Tiantao Gao, Ningyu Wang, Qiang Feng, Xinyu You, Tinghong Ye, Qian Lei, Yongxia Zhu, Menghua Xiong, Yong Xia, Fangfang Yang, Yaojie Shi, Yuquan Wei, Lidan Zhang, Luoting Yu*, Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer,Sci Rep., 2016, 6: 20864.
(4) Xuejiao Song, Tiantao Gao, Tinghong Ye, Yongxia Zhu, Qian Lei, Qiang Feng, Bing He, Hongxia Deng, Lidan Zhang, Luoting Yu*, Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation, Biomed Pharmacother, 2016, 81: 288-294.
(5)Lidan Zhang,Xuejiao Song, Ningyu Wang, Lifeng Zhao, Qiang Feng, Xinyu You, Cuiting Peng, Tiantao Gao,Menghua Xiong, Bing He, Chao Gao, Yong Luo, Ying Xu, Qiyi Zhang, Luoting Yu*, Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors, RSC Adv., 2015, 5, 25967-25977.
(6) Yong Xia,Xuejiao Song, Deliang Li, Tinghong Ye, Hongjun Lin, Nana Meng, Guobo Li, Senyi Deng, Shuang Zhang, Li Liu, Yongxia Zhu, Jun Zeng, Qian Lei, Youli Pan, Yuquan Wei, Yinglan Zhao, Luoting Yu*, YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models, Sci Rep., 2014, 4: 6013.
(7)Xuejiao Song, Xia Yong, Ning-yu Wang, Li-dan Zhang, Xuan-hong Shi, You-zhi Xu, Ting-hong Ye, Yao-jie Shi, Yong-xia Zhu, Luo-ting Yu*, A Novel Benzothiazole Derivative YLT322 Induces Apoptosis via the Mitochondrial Apoptosis Pathway In Vitro with Anti-Tumor Activity in Solid Malignancies,PLoS One,2013, 8(5): e63900.
